 Summary of this article
- Polycystic Ovary Syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) after a global medical consensus.
- Experts said the old term failed to reflect the disorder’s wider hormonal, metabolic and mental health effects.
- Doctors hope the new name will improve awareness, diagnosis and long-term treatment of the condition.
Polycystic Ovary Syndrome (PCOS), a condition that affects around 1 in 8 women around the world, has just received a name change. It will now be known as Polyendocrine Metabolic Ovarian Syndrome (PMOS) after a global consensus reached by international endocrine and reproductive health experts.
According to many experts the name was misleading as many women suffering from PCOS did not develop ovarian cysts. The name also ignored the effect the syndrome had on metabolism, hormones, mental health and cardiovascular risk.
In India where millions of women are affected by PCOS, the condition often remains undiagnosed. It is often misunderstood as a fertility issue rather than a hormonal problem that lasts a lifetime.
Prediabetes Remission Sharply Lowers Long-Term Heart Risk, Study Shows
BY Archana Jyoti |
